跳转至内容
Merck
CN

SML2768

Sigma-Aldrich

Vicriviroc Maleate

≥98% (HPLC)

别名:

(4,6-Dimethyl-5-pyrimidinyl)[4-[(3S)-4-[(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl]-3-methyl-1-piperazinyl]-4-methyl-1-piperidinyl]methanone Maleate, MK 7690, SCH 417690, SCH-D

登录查看公司和协议定价

选择尺寸


关于此项目

经验公式(希尔记法):
C28H38F3N5O2·C4H4O4
化学文摘社编号:
分子量:
649.70
MDL编号:
UNSPSC代码:
12352200
NACRES:
NA.77
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

质量水平

方案

≥98% (HPLC)

表单

powder

储存条件

desiccated

颜色

white to beige

溶解性

DMSO: 2 mg/mL, clear

储存温度

−20°C

SMILES字符串

O=C(/C=C\C(O)=O)O.FC(F)(F)C(C=C1)=CC=C1[C@H](COC)N([C@@H](C)C2)CCN2C(CC3)(C)CCN3C(C4=C(C)N=CN=C4C)=O

InChI

1S/C28H38F3N5O2.C4H4O4/c1-19-16-35(14-15-36(19)24(17-38-5)22-6-8-23(9-7-22)28(29,30)31)27(4)10-12-34(13-11-27)26(37)25-20(2)32-18-33-21(25)3;5-3(6)1-2-4(7)8/h6-9,18-19,24H,10-17H2,1-5H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t19-,24-;/m0./s1

InChI key

GXINKQQWHLIBJA-UCIBKFKQSA-N

生化/生理作用

Inhibitor of chemokine CCR5 receptors; Antiretroviral entry inhibitor
Vicriviroc is an orally available, potent and selective allosteric antagonist of C-C chemokine CCR5 receptors. Vicriviroc inhibits the interaction of HIV-1 with CCR5 receptor thereby preventing HIV-1 virus entry into cells.

储存分类代码

11 - Combustible Solids

WGK

WGK 3

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Reem Berro et al.
Journal of virology, 87(12), 6569-6581 (2013-03-08)
Small-molecule CCR5 inhibitors such as vicriviroc (VVC) and maraviroc (MVC) are allosteric modulators that impair HIV-1 entry by stabilizing a CCR5 conformation that the virus recognizes inefficiently. Viruses resistant to these compounds are able to bind the inhibitor-CCR5 complex while
Paul McNicholas et al.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 55(2), 134-139 (2012-07-25)
Vicriviroc (VCV), a small-molecule antagonist of the C-C chemokine receptor 5 (CCR5), blocks HIV's entry into CD4+ cells. Small studies have suggested that resistance to CCR5 antagonists is slow to develop. To examine resistance to VCV in isolates from treatment
Xuanmao Jiao et al.
Cancer research, 78(7), 1657-1671 (2018-01-24)
The functional significance of the chemokine receptor CCR5 in human breast cancer epithelial cells is poorly understood. Here, we report that CCR5 expression in human breast cancer correlates with poor outcome. CCR5+ breast cancer epithelial cells formed mammospheres and initiated

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持